| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |